IT'S BEEN a rat race to get the patent. But Harvard University's onco-mouse, a creature designed in a laboratory for cancer research, may still not make it.
In mid-May, shortly after the European Patent Office published its patent for this mouse that has been given cancer-causing genes, European green activists went to court challenging the patent on both technical and moral grounds. They argue that the European Patent Convention prohibits the patenting of "types of animals".
But while environmental and animal activists in every country in Europe gear up to fight the patent, the European biotechnology industry is afraid the never-ending battle over patents will drive business to USA, which allows patenting for transgenic animals.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
.png)
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.